These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33536719)

  • 1. The simplified Kyoto classification score is consistent with the ABC method of classification as a grading system for endoscopic gastritis.
    Nishizawa T; Toyoshima O; Kondo R; Sekiba K; Tsuji Y; Ebinuma H; Suzuki H; Tanikawa C; Matsuda K; Koike K
    J Clin Biochem Nutr; 2021 Jan; 68(1):101-104. PubMed ID: 33536719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic Kyoto classification of
    Toyoshima O; Nishizawa T; Koike K
    World J Gastroenterol; 2020 Feb; 26(5):466-477. PubMed ID: 32089624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistency between the endoscopic Kyoto classification and pathological updated Sydney system for gastritis: A cross-sectional study.
    Toyoshima O; Nishizawa T; Yoshida S; Matsuno T; Odawara N; Toyoshima A; Sakitani K; Watanabe H; Fujishiro M; Suzuki H
    J Gastroenterol Hepatol; 2022 Feb; 37(2):291-300. PubMed ID: 34569096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of endoscopic gastritis based on Kyoto classification between diffuse and intestinal gastric cancer.
    Toyoshima O; Nishizawa T; Yoshida S; Aoki T; Nagura F; Sakitani K; Tsuji Y; Nakagawa H; Suzuki H; Koike K
    World J Gastrointest Endosc; 2021 May; 13(5):125-136. PubMed ID: 34046150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopy-based Kyoto classification score of gastritis related to pathological topography of neutrophil activity.
    Toyoshima O; Nishizawa T; Yoshida S; Sakaguchi Y; Nakai Y; Watanabe H; Suzuki H; Tanikawa C; Matsuda K; Koike K
    World J Gastroenterol; 2020 Sep; 26(34):5146-5155. PubMed ID: 32982115
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Toyoshima O; Nishizawa T; Sakitani K; Yamakawa T; Takahashi Y; Kinoshita K; Torii A; Yamada A; Suzuki H; Koike K
    JGH Open; 2020 Oct; 4(5):909-914. PubMed ID: 33102763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enlarged folds on endoscopic gastritis as a predictor for submucosal invasion of gastric cancers.
    Toyoshima O; Yoshida S; Nishizawa T; Toyoshima A; Sakitani K; Matsuno T; Yamada T; Matsuo T; Nakagawa H; Koike K
    World J Gastrointest Endosc; 2021 Sep; 13(9):426-436. PubMed ID: 34630892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kyoto classification of gastritis: Advances and future perspectives in endoscopic diagnosis of gastritis.
    Toyoshima O; Nishizawa T
    World J Gastroenterol; 2022 Nov; 28(43):6078-6089. PubMed ID: 36483157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer.
    Sugimoto M; Ban H; Ichikawa H; Sahara S; Otsuka T; Inatomi O; Bamba S; Furuta T; Andoh A
    Intern Med; 2017; 56(6):579-586. PubMed ID: 28321054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between gastric cancer and the Kyoto classification of gastritis.
    Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Koike K
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1581-1586. PubMed ID: 28217843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of endoscopic features for the diagnosis of Helicobacter pylori infection status based on the Kyoto classification of gastritis.
    Yoshii S; Mabe K; Watano K; Ohno M; Matsumoto M; Ono S; Kudo T; Nojima M; Kato M; Sakamoto N
    Dig Endosc; 2020 Jan; 32(1):74-83. PubMed ID: 31309632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single nucleotide polymorphism in
    Toyoshima O; Nishizawa T; Sekiba K; Matsuno T; Kondo R; Watanabe H; Suzuki H; Tanikawa C; Koike K; Matsuda K
    J Clin Biochem Nutr; 2021 Jan; 68(1):73-77. PubMed ID: 33536715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer incidence based on endoscopic Kyoto classification of gastritis.
    Toyoshima O; Nishizawa T; Yoshida S; Matsuno T; Fujisawa G; Toyoshima A; Ebinuma H; Fujishiro M; Saito Y; Suzuki H
    World J Gastroenterol; 2023 Aug; 29(31):4763-4773. PubMed ID: 37664152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of risk score using Kyoto classification of gastritis a few years prior to diagnosis of early gastric cancer.
    Fujimoto Y; Katayama Y; Gyotoku Y; Oura R; Kobori I; Kitagawa T; Tamano M
    JGH Open; 2021 Feb; 5(2):280-285. PubMed ID: 33553668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic findings of
    Hojo M; Nagahara A; Kudo T; Takeda T; Ikuse T; Matsumoto K; Ueda K; Ueyama H; Matsumoto K; Asaoka D; Shimizu T
    JGH Open; 2021 Oct; 5(10):1197-1202. PubMed ID: 34622008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different risk stratifications for gastric cancer and establishing a simplified risk-scoring model based on the Kyoto classification.
    Zhang P; Xu T; Wang J; Li Y; Cai Y; Feng H; Wang Y
    J Gastroenterol Hepatol; 2023 Nov; 38(11):1988-1997. PubMed ID: 37621083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Cyclooxygenase-2 1195 G-Carrier Genotype Associated with Intestinal Metaplasia and Endoscopic Findings Based on Kyoto Classification.
    Kodaka Y; Futagami S; Tatsuguchi A; Yamawaki H; Sato H; Hashimoto S; Kawagoe T; Ueki N; Nagoya H; Maruki Y; Miyake K; Gudis K; Sakamoto C; Iwakiri K
    Digestion; 2017; 96(3):173-183. PubMed ID: 28946145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness and Limitations of a Serum Screening System to Predict the Risk of Gastric Cancer.
    Kishino T; Oyama T; Tomori A; Takahashi A; Shinohara T
    Intern Med; 2020 Jun; 59(12):1473-1480. PubMed ID: 32188803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum anti-
    Toyoshima O; Nishizawa T; Sakitani K; Yamakawa T; Takahashi Y; Yamamichi N; Hata K; Seto Y; Koike K; Watanabe H; Suzuki H
    World J Gastroenterol; 2018 Sep; 24(35):4061-4068. PubMed ID: 30254410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of serum anti-
    Nishizawa T; Sakitani K; Suzuki H; Yamakawa T; Takahashi Y; Yamamichi N; Watanabe H; Seto Y; Koike K; Toyoshima O
    United European Gastroenterol J; 2019 Apr; 7(3):343-348. PubMed ID: 31019702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.